Zhang Meng, Yang Dong, Meng Xiangyu, Liu Yuanlin, Zhang Tao
Department of Gastric Surgery, Cancer Hospital of Dalian University of Technology//Liaoning Cancer Hospital, Shenyang, Liaoning, China.
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251356439. doi: 10.1177/15330338251356439. Epub 2025 Jul 15.
Low temperature plasma (LTP), as an emerging cancer treatment technology, has shown significant therapeutic potential due to its unique physical and chemical properties and biological effects. This article reviews the basic characteristics of LTP and its multiple mechanisms of application in tumor treatment. LTP can induce various cell death modes, including apoptosis, pyroptosis, and autophagy, through its unique chemical and physical properties. Additionally, studies have demonstrated that the combination of LTP with traditional chemotherapy drugs (such as cisplatin and paclitaxel) can enhance the anti-tumor efficacy of the drugs while reducing drug resistance. The combined application of LTP and nanomaterials also shows promising prospects. However, LTP still faces some challenges and limitations in medical applications. Future research needs to further explore the specific applications of LTP in different tumor types, optimize treatment plans, and develop more portable and efficient LTP devices to promote its application in clinical treatment.
低温等离子体(LTP)作为一种新兴的癌症治疗技术,因其独特的物理化学性质和生物学效应而展现出显著的治疗潜力。本文综述了低温等离子体的基本特性及其在肿瘤治疗中的多种应用机制。低温等离子体可通过其独特的化学和物理性质诱导多种细胞死亡模式,包括凋亡、焦亡和自噬。此外,研究表明,低温等离子体与传统化疗药物(如顺铂和紫杉醇)联合使用可增强药物的抗肿瘤疗效,同时降低耐药性。低温等离子体与纳米材料的联合应用也显示出广阔的前景。然而,低温等离子体在医学应用中仍面临一些挑战和限制。未来的研究需要进一步探索低温等离子体在不同肿瘤类型中的具体应用,优化治疗方案,并开发更便携、高效的低温等离子体设备,以促进其在临床治疗中的应用。